Umer Waseem, Umer Naseem, Ali Elrazi A, Abubakar Muhammad, Yassin Mohamed A
Internal Medicine, Hamad General Hospital, Doha, QAT.
Medicine, Hamad Medical Corporation, Doha, QAT.
Cureus. 2022 Aug 29;14(8):e28550. doi: 10.7759/cureus.28550. eCollection 2022 Aug.
Polycythemia vera (PV) is a myeloid stem cell disorder characterized by excess red cell mass. The two major complications of PV are thrombosis and bleeding. Atrial fibrillation is a potentially devastating condition that can complicate the course of PV. We describe a case of a 65-year-old woman with PV who presented with new-onset atrial fibrillation. The atrial fibrillation was aborted successfully, and the patient was started on oral anticoagulation with rivaroxaban. PV with atrial fibrillation poses a challenge in management due to the risk of thrombosis and bleeding. Despite the lack of standard recommendations or guidelines, this case highlights that oral anticoagulation therapy can be safe and convenient for such patients.
真性红细胞增多症(PV)是一种以红细胞增多为特征的髓系干细胞疾病。PV的两个主要并发症是血栓形成和出血。心房颤动是一种可能具有破坏性的疾病,可使PV病程复杂化。我们描述了一例65岁患有PV的女性,她出现了新发心房颤动。心房颤动成功转复,患者开始接受利伐沙班口服抗凝治疗。PV合并心房颤动由于存在血栓形成和出血风险,在管理上具有挑战性。尽管缺乏标准的建议或指南,但该病例表明口服抗凝治疗对此类患者可能是安全且方便的。